Table 1 Malaria vaccine projects funded by the EC FP5
Project | Project | Coordinator | Partner | EC Contribution | Duration | Start |
|---|---|---|---|---|---|---|
Acronym | Type | Name/Institution | Numbers | Euros | Months | Date |
EUROMALVAC1 | RS | D. Arnot, University of Edinburgh, UK | 10 | 3 500 000 | 36 | 01-02-2000 |
ATTMAL | RS | A. Waters, Leiden University, NL | 5 | 1 492 640 | 36 | 01-03-2000 |
MALTRANS | RS | R. Sauerwein, Radboud University Nijmegen Medical Centre, NL | 11 | 2 499 962 | 36 | 01-03-2000 |
AMVTNETHIC | AM | S. Jepsen, Statens Serum Institut, DK | 1 | 220 000 | 36 | 01-04-2000 |
PAMVAC | RS | M. Klinkert, Bernhard-Nocht-Institute for Tropical Medicine, DE | 6 | 1 503 210 | 36 | 01-09-2001 |
NEMLAR | AM | S. Jepsen, Statens Serum Institut, DK | 1 | 70 000 | 36 | 01-12-2001 |
EMLI | DM | P. Druilhe, Institut Pateur, FR | 7 | 1 462 733 | 36 | 01-01-2002 |
EMVI | AM | S. Jepsen, Statens Serum Institut, DK | 2 | 700 000 | 36 | 01-08-2002 |
EUROMALVAC2 | RS | D. Arnot, University of Edinburgh, UK | 12 | 3 700 044 | 36 | 01-09-2002 |
VIRIMAL | RS | P. Preiser, Medical Research Council, UK | 5 | 1 196 180 | 36 | 01-09-2002 |
AMVTN/AMANET | CA | S. Jepsen, Statens Serum Institut, DK | 16 | 1 000 000 | 36 | 01-11-2002 |
Total EC contribution under FP5 | 17 344 769 | |||||